5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hepatocellular Carcinoma in Malaysia and Its Changing Trend

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepatocellular carcinoma (HCC) is one of the leading causes of death globally. In Malaysia liver cancer is the eighth most common cause of cancer for both gender and fifth most common cause of cancer for males. Liver cancer is a cause of premature death in Malaysia: The trend from 1990 to 2010 was observed upward. Since 1990, the annual years of life lost (YLLs) from liver cancer have increased by 31.5%. Older persons are at higher risk and there is male predominance observed. Curative surgical resection, liver transplantation, and supportive symptomatic care, including percutaneous ethanol injection and radiofrequency ablation (RFA), and noncurative transarterial chemoembolization (TACE) are among available treatment facilities. Yet the survival rate is very poor as majority of patients present at very advanced stage. Hepatitis B virus (HBV) remained the leading cause of HCC in Malaysia. Several studies showed cryptogenic causes, which are mainly nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) among the predominant causes of HCC in Malaysia than hepatitis C virus (HCV), alcohol, or any other reason. This mainly correlates with the increasing incidence of diabetes and obesity in Malaysia.

          How to cite this article: Raihan R, Azzeri A, Shabaruddin FH, Mohamed R. Hepatocellular Carcinoma in Malaysia and Its Changing Trend. Euroasian J Hepato-Gastroenterol 2018;8(1):54-56.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Diagnosis of hepatocellular carcinoma.

          Hepatocellular carcinoma (HCC) is responsible for a large proportion of cancer deaths worldwide. HCC is frequently diagnosed after the development of clinical deterioration at which time survival is measured in months. Long-term survival requires detection of small tumors, often present in asymptomatic individuals, which may be more amenable to invasive therapeutic options. Surveillance of high-risk individuals for HCC is commonly performed using the serum marker alpha-fetoprotein (AFP) often in combination with ultrasonography. Various other serologic markers are currently being tested to help improve surveillance accuracy. Diagnosis of HCC often requires more sophisticated imaging modalities such as CT scan and MRI, which have multiphasic contrast enhancement capabilities. Serum AFP used alone can be helpful if levels are markedly elevated, which occurs in fewer than half of cases at time of diagnosis. Confirmation by liver biopsy can be performed under circumstances when the diagnosis of HCC remains unclear.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.

            There is currently no published study comparing prevalence of non-alcoholic fatty liver disease (NAFLD) and associated factors among diabetics of different ethnicity in the Asia-Pacific region.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia.

              The implementation of the Expanded Program of Immunization (EPI) in 1989 has dramatic impact on hepatitis B virus (HBV) infection in school children in Malaysia. A cross-sectional seroprevalence study of HBV infection in 190,077 school children aged 7-12 years from 1997 to 2003 showed a steady decline of HBV surface antigen (HBsAg) prevalence rate from 2.5% for children born in 1985 to 0.4% among school children born in 1996. The overall prevalence of HBsAg was 0.6%, 0.7% in males and 0.6% in females. Over 92.7% of school children had been vaccinated with HBV vaccine, in which 93.7% were vaccinated under the EPI and 6.3% on voluntary basis. The school children vaccinated under EPI had a 0.4% HBsAg carrier rate, which was significantly lower than school children vaccinated on a voluntary basis (HBsAg carrier rate 1.3%) and non-vaccinated school children (HBsAg carrier rate 2.7%), suggesting that HBV vaccination of infants was the most effective measure in preventing vertical transmission of HBV in the hyperendemic region.
                Bookmark

                Author and article information

                Journal
                Euroasian J Hepatogastroenterol
                Euroasian J Hepatogastroenterol
                EJOHG
                Euroasian Journal of Hepato-Gastroenterology
                Jaypee Brothers Medical Publishers
                2231-5047
                2231-5128
                Jan-Jun 2018
                01 May 2018
                : 8
                : 1
                : 54-56
                Affiliations
                [1 ]Department of Microbiology, Faculty of Medicine, AIMST University, Kedah, Malaysia
                [2 ]Department of Social and Preventive Medicine Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
                [3 ]Department of Pharmacy, Faculty of Medicine, University of Malaya Kuala Lumpur, Malaysia
                [4 ]Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
                Author notes
                Address reprint requests to: Ruksana Raihan, Department of Microbiology, Faculty of Medicine, AIMST University, Kedah, Malaysia e-mail: ruksanaraihan@gmail.com
                Article
                10.5005/jp-journals-10018-1259
                6024046
                29963463
                e4cca98d-2195-4dc3-9822-7d2c5538e552
                Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.

                This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/

                History
                : 6 January 2018
                : 10 February 2018
                Categories
                Mini-Review

                cryptogenic,hepatocellular carcinoma,malaysia,nonalcoholic fatty liver disease,nonalcoholic steatohepatitis.

                Comments

                Comment on this article